ImmuCell names Olivier te Boekhorst CEO; board expanded to nine directors

IMMUCELL CORP /DE/

Olivier te Boekhorst started as President and CEO on Nov 1, 2025, succeeding Michael Brigham.
Board expanded from 7 to 9 directors; te Boekhorst and CFO Timothy Fiori elected as directors.
Michael Brigham remains board member and Special Advisor to CEO until January 2026.
CFO Fiori also appointed Secretary and Treasurer.
Company to host Q3 earnings conference call on Nov 14, 2025 at 9:00 AM ET.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.